Efficacy and safety of high-dose cabergoline in Parkinson's disease.
Odin P, Oehlwein C, Storch A, Polzer U, Werner G, Renner R, Shing M, Ludolph A, Schüler P.
Odin P, et al. Among authors: schuler p.
Acta Neurol Scand. 2006 Jan;113(1):18-24. doi: 10.1111/j.1600-0404.2005.00514.x.
Acta Neurol Scand. 2006.
PMID: 16367894
Clinical Trial.